Serim Research Corporation

PO BOX 4002
Elkhart, IN 46514
35 Employees

SBIR Award Summary

Total Number of Awards 5
Total Value of Awards $49.8K
First Award Date 03/01/90
Most Recent Award Date 09/30/92

Key Personnel

Last Name Name Awards Contact
Hemmes Dr. Paul R Hemmes 1
Carrico Robert J Carrico 2
Christner James E Christner 2

5 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/92 - 05/31/93

Microalbuminuria is a marker for the onset of incipient nephropathy, a condition that affects 35% of Type I diabetics. Incipient nephropathy develops over a period of years into end stage renal disease. The cost of care for diabetic patients with end stage renal disease is about $750 million per year. Early glycemic regulation and therapeutic...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/92 - 04/30/93

DESCRIPTION: (Adapted from the applicant's abstract) Culture of urine is the usual method for diagnosis of bacteriuria in clinical microbiology laboratories. About 65 million urine specimens are tested by this method per year in the U.S. Each specimen is plated on two media in order to detect important gram positive and gram negative results...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/01/90 - 03/31/91

Chloramines are strongly hemolytic and therefore are highly toxic to hemodialysis patients. Purified water for dialysis should not contain more than 0.1 ppm of chloramines. Presently, there is not a test available for the direct measurement of chloramines. Rather, the level of chloramines is obtained by calculation of the difference between t...

Phase 1 SBIR

Agency: Navy
Topic: N90-059
Budget: 08/01/90 - 02/01/91

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/90 - 08/31/90

Microalbuminuria is prognostic of diabetic nephropathy, a condition that affects about 35% of Type I diabetics. It is estimated that the cost of care for uremic diabetic patients will soon reach $2 billion a year. Recent evidence indicates that early therapeutic intervention slows or halts the development of renal disease. The overall goal of ...